A blood test was able to predict the risk of dementia in women up to 25 years before symptoms appear, according to a new ...

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier ...

Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms ...

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer's disease at its very earliest stage, even before symptoms appear.

La Jolla researchers say there is a pressing need for cost-effective tests for markers of Alzheimer’s disease and related dementia in groups considered underrepresented in studies — particularly ...

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...